Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2024

Equity [Abstract]

Schedule of Changes in Outstanding Stock

The following table reflects the changes in our outstanding stock:

	Class A(2)		Class B-1			Class B-2			Class V			Class Z			Treasury
Balance at December 31, 2023		507,567,678		4,951,235			4,951,235			28,962,218			3,420,215			6,427,853
Conversion of noncontrolling interest		27,773,062		—			—			(27,773,062	)		—			—
Shares granted upon vesting		13,890,962		—			—			—			(2,842,116	)		—
Issuance for compensation to non-employees(1)		17,802		—			—			—			—			—
Share repurchases		—		—			—			—			—			—
Share forfeitures		—		(18,148	)		(18,148	)		—			—			—
Balance at March 31, 2024		549,249,504		4,933,087			4,933,087			1,189,156			578,099			6,427,853

(1) Issued to certain members of the Board of Directors in lieu of cash retainer.

(2) Does not include 712,237 of unvested Class A common shares as of March 31, 2024.

Schedule of Changes in Accumulated Other Comprehensive Income, Net by Component

Changes in accumulated other comprehensive income, net of noncontrolling interests, are as follows (in millions):

		Foreign
		Currency				Interest
		Translation				Rate
		Adjustments (1)				Swaps (2)			Total
Balance at December 31, 2023	$		(3	)	$		74		$	71
Other comprehensive income (loss) before reclassifications			(4	)			30			26
Tax (expense) benefit			1				(1	)		-
Other comprehensive income (loss) before reclassifications, net of tax			(3	)			29			26
Amounts reclassified from accumulated other comprehensive income			-				(22	)		(22	)
Tax expense			-				-			-
Amounts reclassified from accumulated other comprehensive income, net of tax			-				(22	)		(22	)
Net current period other comprehensive income (loss), net of tax			(3	)			7			4
Balance at March 31, 2024	$		(6	)	$		81		$	75

(1) Foreign currency translation adjustments include $1 million loss related to intercompany loans that have been designated long-term investment nature.

(2) Reclassifications from this category are recorded in Interest expense. See Note 13 “Derivative Financial Instruments” for additional information.